+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Technology Type (Cytokines & Immunomodulators, Monoclonal Antibodies), Indication, Institution Category - Global Forecast 2025-2030- Product Image
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Technology Type (Cytokines & Immunomodulators, Monoclonal Antibodies), Indication, Institution Category - Global Forecast 2025-2030- Product Image
Sale

Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Technology Type (Cytokines & Immunomodulators, Monoclonal Antibodies), Indication, Institution Category - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011253
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cellular immunotherapy market is undergoing significant transformation as advanced science, data-driven approaches, and cross-sector partnerships converge to shape the next era in cancer treatment. Senior leaders seeking to navigate this evolving sector will benefit from a concise, actionable view of current opportunities, challenges, and strategic imperatives.

Market Snapshot: Cellular Immunotherapy Market Size and Growth

The Cellular Immunotherapy Market grew from USD 11.89 billion in 2024 to USD 13.29 billion in 2025. It is expected to continue growing at a CAGR of 12.03%, reaching USD 23.52 billion by 2030. Growth is being driven by rapid scientific advancements, broader patient access, evolving regulatory frameworks, and integration of emerging technologies that support precision oncology and scalable treatment platforms.

Scope & Segmentation

This report presents in-depth analysis and forecasts across multiple segmentation axes:

  • Therapeutic Types: CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, T-Cell Receptor Therapy, Tumor-Infiltrating Lymphocytes Therapy
  • Technology Types: Cytokines & Immunomodulators, Monoclonal Antibodies
  • Indications: B-Cell Malignancies, Liver Cancer, Prostate Cancer, Renal Cell Carcinoma
  • Institution Categories: Academic Institutes, Biotech & Pharmaceutical Companies, Contract Organizations, Hospitals, Research Institutes
  • Regional Coverage: Americas (including United States states such as California, Texas, New York, and others; plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, United Arab Emirates, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and additional markets)
  • Company Coverage: Analysis includes Adaptimmune Therapeutics PLC, AstraZeneca PLC, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, Celyad Oncology SA, Dendreon Pharmaceuticals LLC, Gilead Sciences, Inc., Iovance Biotherapeutics, Inc., Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., among others.

Key Takeaways for Senior Decision-Makers

  • Precision medicine in cellular immunotherapy enables tailored, targeted treatments that align with the evolving landscape of patient needs.
  • Collaboration between academic institutions, biotech, pharmaceutical leaders, and contract organizations is accelerating innovation pipelines and expanding real-world impact.
  • Next-generation gene editing, machine learning integration, and advanced “off-the-shelf” cell therapy manufacturing are streamlining development and enhancing scalability.
  • Adaptive regulatory and reimbursement models are critical to the successful commercialization and adoption of novel cell therapies worldwide.
  • Regional differences in healthcare infrastructure, payer policies, and innovation investment demand market-specific entry and growth strategies.
  • Institutions are prioritizing robust quality protocols, specialized manufacturing infrastructure, and digital analytics capabilities for scalable delivery and real-time monitoring.

Impact of Recent United States Tariffs on Supply Chains

New tariffs on raw materials, reagents, and consumables vital for cellular immunotherapy are shaping operational and financial planning. These policies are prompting manufacturers to rethink sourcing contracts, invest in vertical integration, and establish regional distribution hubs to ensure uninterrupted production. Regulatory agencies are supporting expedited local manufacturing approvals as the market adapts to changing cost structures and competitive pressures.

Methodology & Data Sources

This report utilizes a blend of secondary research, including peer-reviewed literature, regulatory filings, clinical trial databases, and industry publications. Primary data is drawn from direct interviews with sector experts, manufacturing leaders, and clinical investigators. Quantitative and qualitative findings are triangulated and validated through scenario planning and multi-source benchmarking to deliver reliable insights.

Why This Report Matters

  • Enables strategic planning by illuminating growth drivers, risks, and evolving opportunity areas within the cellular immunotherapy market.
  • Supports investment and partnership decisions with robust segment analysis and actionable intelligence across regions, technologies, and competitive landscapes.
  • Provides clarity on regulatory, clinical, and supply chain developments that influence commercialization pathways.

Conclusion

Cellular immunotherapy presents both opportunity and complexity within global oncology. By leveraging evidence-based insights and proactive strategies, stakeholders can position their organizations to lead in this dynamic and rapidly evolving marketplace.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing clinical adoption of CAR-T cell therapies
5.2. Expansion of point-of-care automated cell processing platforms to streamline treatment workflow
5.3. Evolving regulatory frameworks accelerating approval of next-generation gene-edited cellular immunotherapies
5.4. Integration of artificial intelligence and big data analytics optimizing personalized cell therapy manufacturing processes
5.5. Rise of combination therapies pairing CAR-T with checkpoint inhibitors for enhanced efficacy in refractory cancers
5.6. Technological advancements enhancing cell manufacturing efficiency
5.7. Advances in CRISPR-enabled CAR-T cell design drive next-generation immunotherapies
5.8. Strategic partnerships between biotech and pharma drive rapid scale-up of cell therapy manufacturing
5.9. Emerging focus on solid tumor immunotherapy strategies
5.10. Continuous bioreactor innovations boost scalable production yields for next-generation cell therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cellular Immunotherapy Market, by Type
8.1. Introduction
8.2. CAR T-Cell Therapy
8.3. Dendritic Cell Therapy
8.4. NK Cell Therapy
8.5. T-Cell Receptor Therapy
8.6. Tumor-Infiltrating Lymphocytes Therapy
9. Cellular Immunotherapy Market, by Technology Type
9.1. Introduction
9.2. Cytokines & Immunomodulators
9.3. Monoclonal Antibodies
10. Cellular Immunotherapy Market, by Indication
10.1. Introduction
10.2. B-Cell Malignancies
10.3. Liver Cancer
10.4. Prostate Cancer
10.5. Renal Cell Carcinoma
11. Cellular Immunotherapy Market, by Institution Category
11.1. Introduction
11.2. Academic Institutes
11.3. Biotech & Pharmaceutical Companies
11.4. Contract Organizations
11.5. Hospitals
11.6. Research Institutes
12. Americas Cellular Immunotherapy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cellular Immunotherapy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cellular Immunotherapy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Adaptimmune Therapeutics PLC
15.3.2. Adicet Bio, Inc.
15.3.3. Apac Biotech Private Limited
15.3.4. AstraZeneca PLC
15.3.5. Atara Biotherapeutics, Inc.
15.3.6. Bellicum Phamaceuticals, Inc.
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. Bristol-Myers Squibb Company
15.3.9. Celyad Oncology SA
15.3.10. Corning Incorporated
15.3.11. Dendreon Pharmaceuticals LLC
15.3.12. Eli Lilly and Company
15.3.13. F. Hoffmann-La Roche AG
15.3.14. Gilead Sciences, Inc.
15.3.15. GlaxoSmithKline PLC
15.3.16. Glycostem Therapeutics B.V.
15.3.17. Immatics N.V.
15.3.18. Inovio Pharmaceuticals, Inc.
15.3.19. Iovance Biotherapeutics, Inc.
15.3.20. Johnson & Johnson Services, Inc.
15.3.21. JW Therapeutics (Shanghai) Co., Ltd.
15.3.22. Lonza Group Ltd.
15.3.23. Merck KGaA
15.3.24. Novartis AG
15.3.25. Pfizer Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELLULAR IMMUNOTHERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CELLULAR IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CELLULAR IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CELLULAR IMMUNOTHERAPY MARKET: RESEARCHAI
FIGURE 24. CELLULAR IMMUNOTHERAPY MARKET: RESEARCHSTATISTICS
FIGURE 25. CELLULAR IMMUNOTHERAPY MARKET: RESEARCHCONTACTS
FIGURE 26. CELLULAR IMMUNOTHERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELLULAR IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY CAR T-CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY CAR T-CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY NK CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY NK CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY T-CELL RECEPTOR THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY T-CELL RECEPTOR THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TUMOR-INFILTRATING LYMPHOCYTES THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TUMOR-INFILTRATING LYMPHOCYTES THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY CYTOKINES & IMMUNOMODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY CYTOKINES & IMMUNOMODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY B-CELL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY B-CELL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY CONTRACT ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY CONTRACT ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 70. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 71. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 72. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 73. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 76. CANADA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 77. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 80. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 81. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 84. MEXICO CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 85. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 86. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 93. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 94. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 118. UNITED KINGDOM CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 119. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 120. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 122. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 123. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 126. GERMANY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 127. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 128. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 129. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 130. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 131. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 134. FRANCE CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 135. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 136. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 137. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 138. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 139. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 142. RUSSIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 143. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 144. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 146. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 147. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 150. ITALY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 151. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 154. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 155. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 158. SPAIN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 170. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 174. SAUDI ARABIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 176. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 178. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 182. SOUTH AFRICA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 183. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 186. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 187. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 190. DENMARK CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 191. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 192. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 194. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 195. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 198. NETHERLANDS CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 199. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 200. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 201. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 202. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 203. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 206. QATAR CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 207. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 210. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 211. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 214. FINLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 215. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 218. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 219. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 222. SWEDEN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 223. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 226. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 227. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 230. NIGERIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 231. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 232. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 233. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 234. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 235. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 238. EGYPT CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 239. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 240. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 241. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 242. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 243. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 246. TURKEY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 247. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 250. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 251. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 254. ISRAEL CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 255. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 256. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 257. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 258. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 259. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 262. NORWAY CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 263. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 266. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 267. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 270. POLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 271. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 272. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 273. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 274. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 275. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 278. SWITZERLAND CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 282. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 286. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. ASIA-PACIFIC CELLULAR IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 290. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 291. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 292. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 293. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 296. CHINA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 297. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 298. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 299. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 300. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 301. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 304. INDIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 305. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 306. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 307. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 308. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 309. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 312. JAPAN CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 313. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 314. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 315. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 316. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 317. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 320. AUSTRALIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 321. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 324. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 325. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2018-2024 (USD MILLION)
TABLE 328. SOUTH KOREA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY INSTITUTION CATEGORY, 2025-2030 (USD MILLION)
TABLE 329. INDONESIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 330. INDONESIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 331. INDONESIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 332. INDONESIA CELLULAR IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 3

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cellular Immunotherapy market report include:
  • Adaptimmune Therapeutics PLC
  • Adicet Bio, Inc.
  • Apac Biotech Private Limited
  • AstraZeneca PLC
  • Atara Biotherapeutics, Inc.
  • Bellicum Phamaceuticals, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • Celyad Oncology SA
  • Corning Incorporated
  • Dendreon Pharmaceuticals LLC
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Glycostem Therapeutics B.V.
  • Immatics N.V.
  • Inovio Pharmaceuticals, Inc.
  • Iovance Biotherapeutics, Inc.
  • Johnson & Johnson Services, Inc.
  • JW Therapeutics (Shanghai) Co., Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.52 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

T-Cell Immunotherapy Market by Therapy Type (CAR-T Therapy, TCR Therapy, TIL Therapy), Cell Source (Allogeneic Cells, Autologous Cells), Target Antigens, Manufacturing Method, Patient Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

T-Cell Immunotherapy Market by Therapy Type (CAR-T Therapy, TCR Therapy, TIL Therapy), Cell Source (Allogeneic Cells, Autologous Cells), Target Antigens, Manufacturing Method, Patient Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Cancer Immunotherapy Market by Therapy Type (Cancer Vaccines, CAR-T Therapy, CTLA-4 Inhibitors), Mechanism Of Action (Adoptive Cell Transfer, Checkpoint Inhibitors, Cytokine Therapy), Line Of Therapy, Route Of Administration, Indication, End User - Global Forecast 2025-2030 - Product Image

Cancer Immunotherapy Market by Therapy Type (Cancer Vaccines, CAR-T Therapy, CTLA-4 Inhibitors), Mechanism Of Action (Adoptive Cell Transfer, Checkpoint Inhibitors, Cytokine Therapy), Line Of Therapy, Route Of Administration, Indication, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Cellular Immunotherapy Market Report 2025 - Product Image

Cellular Immunotherapy Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cellular Immunotherapy - Global Strategic Business Report - Product Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Global Cell Based Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Cell Based Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From

About the Cellular Immunotherapy Market

Cellular Immunotherapy is a type of Immune Disorders Drugs that uses a patient's own immune cells to treat diseases. It is a form of personalized medicine that is tailored to the individual patient's needs. It works by stimulating the patient's own immune system to recognize and attack cancer cells or other diseased cells. It can also be used to treat autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis. Cellular Immunotherapy is a rapidly growing field, with many companies developing new treatments and technologies. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing new treatments for immune disorders. Other companies, such as Celgene, are also researching and developing new treatments for immune disorders. Additionally, many universities and research institutions are conducting research into the potential of Cellular Immunotherapy. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.